OmniAb, Inc.
OABI
Cena:
$ 2.65
+0.10 (3.92%)
Valuace
93
Růst
23
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
LAUNCH OF OMNIULTRA EXPANDS OMNIAB'S REACH INTO NEW MARKETS AND APPLICATIONS, ADVANCES LEADERSHIP IN ANTIBODY DISCOVERY TECHNOLOGIES
15-12-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) ANNOUNCES THE LAUNC...
Více zde
OMNIAB TO HOLD OMNIULTRA VIRTUAL INVESTOR EVENT ON DECEMBER 15
04-12-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED IT ...
Více zde
OMNIAB ENTERS INTO A TECHNOLOGY LICENSE AND SERVICES AGREEMENT FOR ANTIBODY DISCOVERY WITH A NEWLY-FORMED INCUBATED COMPANY OF ARROWMARK PARTNERS AND VIKING GLOBAL INVESTORS
17-11-2025
EMERYVILLE, CALIF. & DENVER--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) AND ARROWM...
Více zde
OMNIAB REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
04-11-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINA...
Více zde
OMNIAB TO PARTICIPATE IN THREE INVESTOR CONFERENCES IN NOVEMBER
16-10-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THA...
Více zde
OMNIAB TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4
14-10-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) WILL REPORT FINANCIAL RESULTS FOR T...
Více zde
OMNIAB TO PARTICIPATE AT THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
02-09-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THA...
Více zde
OMNIAB ANNOUNCES $30 MILLION PRIVATE PLACEMENT
25-08-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED IT ...
Více zde
OMNIAB REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
06-08-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINA...
Více zde
OMNIAB TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 6
16-07-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) WILL REPORT FINANCI...
Více zde
OMNIAB SHOWCASES INNOVATIVE HIGH-THROUGHPUT SINGLE B-CELL SCREENING XPLORATION® PLATFORM AT THE 21ST ANNUAL PEGS BOSTON SUMMIT
13-05-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED ITS PARTICIPATION I...
Více zde
OMNIAB REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
08-05-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FO...
Více zde
VERAXA BIOTECH ENTERS CO-DISCOVERY ALLIANCE WITH OMNIAB FOR A NOVEL BISPECIFIC ANTIBODY DRUG CONJUGATE PROGRAM
05-05-2025
PARTNERSHIP COMBINES VERAXA'S PROPRIETARY ADC TECHNOLOGY WITH OMNIAB'S ANTIBODY DISCOVERY TECHNOLOGY...
Více zde
OMNIAB TO PARTICIPATE IN FIVE UPCOMING INVESTOR CONFERENCES
01-05-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THAT MANAGEMENT WIL...
Více zde
OMNIAB ANNOUNCES TWO NEW APPOINTMENTS TO ITS BOARD OF DIRECTORS
21-04-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THE APPOINTMENTS OF...
Více zde
OMNIAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
18-03-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FO...
Více zde
OMNIAB TO REPORT FOURTH QUARTER 2024 FINANCIAL RESULTS ON MARCH 18
24-02-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) WILL REPORT FINANCIAL RESULTS FOR T...
Více zde
OMNIAB TO PARTICIPATE IN TWO INVESTOR CONFERENCES IN MARCH
03-02-2025
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THAT MANAGEMENT WIL...
Více zde
KUEHN LAW ENCOURAGES INVESTORS OF OMNIAB, INC. TO CONTACT LAW FIRM
31-01-2025
NEW YORK , JAN. 31, 2025 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVE...
Více zde
OMNIAB TECHNOLOGIES FEATURED IN TWO PRESENTATIONS AT THE 2024 ANTIBODY ENGINEERING & THERAPEUTICS CONFERENCE
16-12-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THAT TWO PRESENTATI...
Více zde
OMNIAB ANNOUNCES PUBLICATION OF SCIENTIFIC PAPER ON HEAVY CHAIN-ONLY SINGLE-DOMAIN ANTIBODY CHICKEN PLATFORM IN THE JOURNAL OF IMMUNOLOGY
03-06-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THE PUBLICATION OF ...
Více zde
OMNIAB TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE
20-05-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THAT MANAGEMENT WIL...
Více zde
OMNIAB PRESENTS HIGH-THROUGHPUT SINGLE B-CELL SCREENING XPLORATION® DATA AT THE 20TH ANNUAL PEGS BOSTON SUMMIT
15-05-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED ITS PARTICIPATION I...
Více zde
OMNIAB REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
09-05-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #ANTIBODY--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED ...
Více zde
OMNIAB TO PARTICIPATE IN FIVE INVESTOR CONFERENCES IN MAY
01-05-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY ANNOUNCED THAT MANAGEMENT WIL...
Více zde
OMNIAB TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
22-04-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) WILL REPORT FINANCIAL RESULTS FOR T...
Více zde
THARIMMUNE ANNOUNCES SCIENTIFIC ADVISORY BOARD TO DRIVE CLINICAL-STAGE LEAD IN CHRONIC LIVER DISEASE AND EARLY-STAGE TUNABLE KNOB DOMAINS FOR GENERATING ANTIBODY DRUG CONJUGATE (ADC) BIOTHERAPEUTICS
15-04-2024
GROUP INCLUDES LEADING EXPERTS IN MULTIPLE DISCIPLINES INCLUDING IMMUNOLOGY, LIVER DISEASES, PROTEIN...
Více zde
OMNIAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
20-03-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FO...
Více zde
OMNIAB TO REPORT FOURTH QUARTER 2023 FINANCIAL RESULTS ON MARCH 20
26-02-2024
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) WILL REPORT FINANCIAL RESULTS FOR T...
Více zde
OMNIAB PRESENTS NEW SCIENTIFIC DATA ON ITS OMNIDAB™ PLATFORM AT THE 2023 ANTIBODY ENGINEERING & THERAPEUTICS CONFERENCE
14-12-2023
EMERYVILLE, CALIF.--(BUSINESS WIRE)--OMNIAB, INC. (NASDAQ: OABI) ANNOUNCES THE PRESENTATION OF NEW S...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-01-30 00:00:00 | 8-K | Stáhnout | |
| 2025-11-04 00:00:00 | 8-K | Stáhnout | |
| 2025-11-04 00:00:00 | 10-Q | Stáhnout | |
| 2025-08-25 01:00:00 | 8-K | Stáhnout | |
| 2025-08-25 00:00:00 | 8-K | Stáhnout | |
| 2025-08-06 01:00:00 | 8-K | Stáhnout | |
| 2025-08-06 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-06 00:00:00 | 8-K | Stáhnout | |
| 2025-08-06 00:00:00 | 10-Q | Stáhnout | |
| 2025-06-18 01:00:00 | 8-K | Stáhnout | |
| 2025-06-18 00:00:00 | 8-K | Stáhnout | |
| 2025-05-08 01:00:00 | 8-K | Stáhnout | |
| 2025-05-08 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-08 00:00:00 | 8-K | Stáhnout | |
| 2025-05-08 00:00:00 | 10-Q | Stáhnout | |
| 2025-04-21 01:00:00 | 8-K | Stáhnout | |
| 2025-04-21 00:00:00 | 8-K | Stáhnout | |
| 2025-03-18 00:00:00 | 8-K | Stáhnout | |
| 2025-03-18 00:00:00 | 10-K | Stáhnout | |
| 2025-03-17 23:00:00 | 8-K | Stáhnout | |
| 2025-03-17 23:00:00 | 10-K | Stáhnout | |
| 2024-11-12 00:00:00 | 8-K | Stáhnout | |
| 2024-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-11 23:00:00 | 8-K | Stáhnout | |
| 2024-11-11 23:00:00 | 10-Q | Stáhnout | |
| 2024-08-08 01:00:00 | 8-K | Stáhnout | |
| 2024-08-08 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-08 00:00:00 | 8-K | Stáhnout | |
| 2024-08-08 00:00:00 | 10-Q | Stáhnout | |
| 2024-07-01 01:00:00 | 8-K | Stáhnout | |
| 2024-07-01 00:00:00 | 8-K | Stáhnout | |
| 2024-06-21 01:00:00 | 8-K | Stáhnout | |
| 2024-06-21 00:00:00 | 8-K | Stáhnout | |
| 2024-05-09 01:00:00 | 8-K | Stáhnout | |
| 2024-05-09 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-09 00:00:00 | 8-K | Stáhnout | |
| 2024-05-09 00:00:00 | 10-Q | Stáhnout | |
| 2024-03-25 00:00:00 | 10-K | Stáhnout | |
| 2024-03-24 23:00:00 | 10-K | Stáhnout | |
| 2024-03-20 00:00:00 | 8-K | Stáhnout | |
| 2024-03-19 23:00:00 | 8-K | Stáhnout | |
| 2023-11-09 00:00:00 | 8-K | Stáhnout | |
| 2023-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-08 23:00:00 | 8-K | Stáhnout | |
| 2023-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2023-11-01 00:00:00 | 8-K | Stáhnout | |
| 2023-10-31 23:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-10 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 00:00:00 | 10-Q | Stáhnout | |
| 2023-06-26 01:00:00 | 8-K | Stáhnout | |
| 2023-06-26 00:00:00 | 8-K | Stáhnout | |
| 2023-05-11 01:00:00 | 8-K | Stáhnout | |
| 2023-05-11 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-11 00:00:00 | 8-K | Stáhnout | |
| 2023-05-11 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-31 01:00:00 | 8-K | Stáhnout | |
| 2023-03-31 00:00:00 | 8-K | Stáhnout | |
| 2023-03-30 01:00:00 | 8-K | Stáhnout | |
| 2023-03-30 01:00:00 | 10-K | Stáhnout | |
| 2023-03-30 00:00:00 | 8-K | Stáhnout | |
| 2023-03-30 00:00:00 | 10-K | Stáhnout | |
| 2023-01-09 00:00:00 | 8-K | Stáhnout | |
| 2023-01-08 23:00:00 | 8-K | Stáhnout | |
| 2022-08-12 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-12 00:00:00 | 10-Q | Stáhnout | |
| 2022-03-28 01:00:00 | 10-K | Stáhnout | |
| 2022-03-28 00:00:00 | 10-K | Stáhnout |
